Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03626844 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Maternal Outcomes Following Manual Lysis of the Placenta.

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened
    • Start date changed from estimate of Jul 2026 to Jul 20, 2026
    • Study site revised
    v5
  2. Lead sponsor: HaEmek Medical Center, Israel to Holy Family Hospital, Nazareth, Israelv4 Show 6 more changesShow less
    • Trial status: Suspended to Not Yet Recruiting
    • Primary completion date: Sep 2020 to Jul 2027
    • Start date: Nov 20, 2018 to Jul 2026
    • Study completion date: Sep 2020 to Aug 2027
    • Secondary endpoints: 6 to 7
    • Study description expanded, about 16 words
  3. Trial status: Recruiting to Suspended Sponsor's reason: Insufficient resources.
    • Site details revised
    v3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 2018 to Nov 20, 2018
    • Eligibility criteria revised
    • Study description revised
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Comparison of maternal outcomes following manual lysis of placenta 15 vs 30 minutes after delivery. A primary outcome of the drop in hemoglobin will be compared between the two groups. Secondary outcomes include blood transfusion rate, maternal satisfaction, time to first breastfeeding, length of hospital stay, infection rate etc.
Trial Details
NCT Number NCT03626844
Lead Sponsor Holy Family Hospital, Nazareth, Israel
Conditions
(from sponsor)		 Third Stage of Delivery
Related terms Postpartum Hemorrhage
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov